Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pancreatic Neoplasms 10Colorectal Neoplasms 5Stomach Neoplasms 3Rhabdomyosarcoma 3Osteosarcoma 3Biliary Tract Neoplasms 3Sarcoma, Ewing 2Recurrence 2Rectal Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Wilms Tumor 1Small Cell Lung Carcinoma 1Small Bowel Adenocarcinoma 1Sarcoma 1Rhabdoid Tumor 1Rectal Cancer Patients 1Peritoneal Neoplasms 1PDAC - Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Nasopharyngeal Carcinoma 1Metastatic Gastric Adenocarcinoma 1Metastatic Adenocarcinoma of the Pancreas 1Malignant Ascites 1Hepatoblastoma 1Gastrointestinal Neoplasms 1Gastroesophageal Junction Adenocarcinoma 1Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

Magnetic Resonance Spectroscopy 8Specimen Handling 7Biopsy 6X-Rays 5Phantoms, Imaging 5Temozolomide 4Nuclear Medicine Department, Hospital 4Nivolumab 4Carboplatin 4selpercatinib 3larotrectinib 3Topotecan 3Etoposide 3Cyclophosphamide 3Cisplatin 3Automobiles 3tazemetostat 2pembrolizumab 2erdafitinib 2entrectinib 2ensartinib 2cabozantinib 2Vincristine 2Surveys and Questionnaires 2Radiotherapy 2Radiosurgery 2Radiation 2Positron-Emission Tomography 2Paclitaxel 2ONC206 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × irinotecan sucrosofate × 1 year × Clear all
NCT03554707 2026-05-08

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

SynerGene Therapeutics, Inc.

Phase EARLY_PHASE1 Withdrawn
CNS

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡